HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Rupture-Associated Choroidal Neovascularization.

AuthorsJonathan F Russell, Thomas A Albini, Audina M Berrocal, Sander R Dubovy, Philip J Rosenfeld, William E Smiddy, Jayanth Sridhar, Justin H Townsend, Harry W Flynn Jr
JournalOphthalmology. Retina (Ophthalmol Retina) Vol. 4 Issue 2 Pg. 226-228 (02 2020) ISSN: 2468-6530 [Electronic] United States
PMID32033715 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiogenesis Inhibitors
  • Vascular Endothelial Growth Factors
  • Ranibizumab
Topics
  • Adult
  • Angiogenesis Inhibitors (administration & dosage)
  • Choroid (injuries)
  • Choroidal Neovascularization (diagnosis, drug therapy, etiology)
  • Eye Injuries (complications, diagnosis)
  • Female
  • Fluorescein Angiography (methods)
  • Fundus Oculi
  • Humans
  • Intravitreal Injections
  • Male
  • Ranibizumab (administration & dosage)
  • Retrospective Studies
  • Rupture
  • Tomography, Optical Coherence (methods)
  • Vascular Endothelial Growth Factors (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: